Asset Planning Corporation’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,661
Closed -$103K 38
2020
Q4
$103K Buy
+1,661
New +$102K 0.1% 41

Other funds holding BMY

Asset Planning Corporation's BMY Position: Q1 2021 in Review

Asset Planning Corporation sold out of Bristol-Myers Squibb (BMY) in Q1 2021, closing a stake of 1,661 shares — an estimated $103K sold.

Asset Planning Corporation first reported a position in BMY in Q4 2020 and held it in 1 quarter. The position peaked at $103K in Q4 2020. 2,368 funds tracked by Wall St. Rank hold BMY as of Q1 2021.

  • Asset Planning Corporation reported no remaining Bristol-Myers Squibb position as of Q1 2021 after selling out during the quarter.
  • Asset Planning Corporation sold 1,661 Bristol-Myers Squibb shares in Q1 2021, an estimated $103K.
  • Asset Planning Corporation first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 1 quarter.
  • Asset Planning Corporation's Bristol-Myers Squibb position peaked at $103K in Q4 2020.
  • 2,368 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2021.

Based on Asset Planning Corporation's 13F filing for Q1 2021, filed 17 May 2021.